The U.S. Food and Drug Administration (FDA) has a commitment to make Sentinel data accessible to the public as soon as possible. Latest Studies Drug Studies View All Skyrizi (Risankizumab-Rzaa) & Signal Identification11/07/2024 Individual Drug Analyses View All Utilization of Risankizumab and Comparator Products: A Descriptive Analysis11/07/2024 Vaccine, Blood, & Biologic Studies View All Fungal Keratitis following Keratoplasty Procedures: A Descriptive Analysis07/29/2021 Device & Radiological Health Studies View All Characterization of Intrauterine Systems (IUS) Insertion and Removal and Oral Contraceptives Dispensings: A Descriptive Analysis01/18/2024